Holen Sie sich die Stockscreener-App
262.37
0.59%
-1.57
Handel nachbörslich:
262.37
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt EFX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$263.94
Offen:
$263.05
24-Stunden-Volumen:
625.30K
Relative Volume:
0.62
Marktkapitalisierung:
$33.77B
Einnahmen:
$5.73B
Nettoeinkommen (Verlust:
$612.30M
KGV:
53.65
EPS:
4.89
Netto-Cashflow:
$808.90M
1W Leistung:
+1.68%
1M Leistung:
+0.37%
6M Leistung:
+4.48%
1J Leistung:
+9.34%
1-Tages-Spanne:
$259.02
$263.66
1-Wochen-Bereich:
$244.51
$264.77
52-Wochen-Spanne:
$199.98
$309.63
Equifax Inc Stock (EFX) Company Profile
Firmenname
Equifax Inc
Sektor
Branche
Telefon
(404) 885-8000
Adresse
1550 PEACHTREE ST NW, ATLANTA, GA
Vergleichen Sie EFX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EFX
Equifax Inc
|
262.37 | 33.77B | 5.73B | 612.30M | 808.90M | 4.89 |
|
VRSK
Verisk Analytics Inc
|
301.21 | 43.68B | 2.93B | 970.70M | 994.10M | 6.83 |
|
BAH
Booz Allen Hamilton Holding Corp
|
108.27 | 12.49B | 11.78B | 870.25M | 844.17M | 6.70 |
|
FCN
Fti Consulting Inc
|
163.86 | 5.48B | 3.73B | 312.01M | 434.78M | 8.70 |
|
HURN
Huron Consulting Group Inc
|
138.39 | 2.42B | 1.47B | 85.47M | 106.27M | 4.60 |
Equifax Inc Stock (EFX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-10 | Fortgesetzt | BofA Securities | Buy |
| 2025-04-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-03-20 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-14 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2025-02-11 | Herabstufung | Argus | Buy → Hold |
| 2024-12-16 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2024-12-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-10-01 | Eingeleitet | UBS | Buy |
| 2024-09-19 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2024-08-13 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-09 | Eingeleitet | Wolfe Research | Outperform |
| 2024-02-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-01-11 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2024-01-08 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-01-04 | Bestätigt | Needham | Buy |
| 2023-12-19 | Eingeleitet | Oppenheimer | Outperform |
| 2023-12-18 | Hochstufung | Jefferies | Hold → Buy |
| 2023-12-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-08 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2023-11-20 | Eingeleitet | Citigroup | Buy |
| 2023-07-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-06 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2022-11-15 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2022-10-21 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-10-19 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-15 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-04-21 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-03-30 | Eingeleitet | Deutsche Bank | Hold |
| 2022-03-11 | Fortgesetzt | BofA Securities | Neutral |
| 2022-01-31 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-01-27 | Hochstufung | Truist | Hold → Buy |
| 2022-01-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-01-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-11-22 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-10-22 | Hochstufung | Argus | Hold → Buy |
| 2021-10-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2021-07-23 | Bestätigt | Goldman | Neutral |
| 2021-07-08 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2020-12-15 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2020-12-11 | Hochstufung | Stifel | Hold → Buy |
| 2020-12-08 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-10-07 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-10-06 | Eingeleitet | Needham | Buy |
| 2020-07-10 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2020-06-09 | Herabstufung | SunTrust | Buy → Hold |
| 2020-05-15 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2020-04-06 | Herabstufung | Argus | Buy → Hold |
| 2020-03-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-02 | Hochstufung | Exane BNP Paribas | Underperform → Outperform |
| 2020-01-17 | Hochstufung | Argus | Hold → Buy |
| 2019-11-22 | Eingeleitet | Jefferies | Buy |
| 2019-03-15 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2019-02-05 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2018-12-07 | Fortgesetzt | Credit Suisse | Outperform |
| 2018-10-26 | Bestätigt | Barclays | Equal Weight |
| 2018-10-23 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-04-10 | Eingeleitet | BofA/Merrill | Underperform |
| 2017-12-14 | Herabstufung | Barclays | Overweight → Equal Weight |
Alle ansehen
Equifax Inc Aktie (EFX) Neueste Nachrichten
Equifax’s SWOT analysis: stock outlook amid mortgage market challenges - Investing.com
Equifax (EFX) Sees Price Target Boosted by Stifel | EFX Stock News - GuruFocus
How To YieldBoost Equifax From 0.8% To 14.7% Using Options - Nasdaq
Equifax stock rating reiterated at Buy by UBS on growth framework - Investing.com India
EFX: RBC Capital Reiterates Outperform Rating with $300 Price Ta - GuruFocus
Equifax (EFX) Price Target Increased by Stifel with Positive Out - GuruFocus
Stifel Adjusts Price Target on Equifax to $295 From $277, Maintains Buy Rating - MarketScreener
Stifel raises Equifax stock price target to $295 on cloud transformation - Investing.com India
Equifax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Transcript : Equifax Inc.Analyst/Investor Day - MarketScreener
Equifax Hack: 5 Biggest Credit Card Data Breaches - Investopedia
NYSE Content Advisory: Pre-Market update + ICE begins trading on NYSE Texas - MarketScreener
Equifax’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Is Equifax Stock Underperforming The Dow? - Barchart.com
Is Equifax Stock Underperforming the Dow? - The Globe and Mail
Equifax Introduces Complete Income™ for Social Services | EFX Stock News - GuruFocus
Equifax Revolutionizes Social Services: New Platform Verifies Gig Worker Income Across 92% of US Banks - Stock Titan
Equifax secures 35 new patents in first half of 2025 in technology-development push - MSN
Equifax’s SWOT analysis: data transformation drives stock amid mortgage woes - Investing.com
Equifax (EFX) Gets a Buy from Needham - The Globe and Mail
There's Been No Shortage Of Growth Recently For Equifax's (NYSE:EFX) Returns On Capital - Yahoo Finance
Equifax (EFX) Enhances Patent Portfolio with New Innovations - GuruFocus
Equifax Secures 35 New Patents, Advancing Responsible AI, Machin - GuruFocus
Equifax (EFX) Expands Patent Portfolio with 35 New Additions in 2025 | EFX Stock News - GuruFocus
Equifax secures 35 new patents in first half of 2025 in technology-development push (EFX:NYSE) - Seeking Alpha
Equifax Secures 35 New Patents - MarketScreener
Equifax Patents 35 New AI Technologies: How Its Latest Innovation Push Transforms Financial Security - Stock Titan
Equifax launches AI-powered credit score planning tool for consumers By Investing.com - Investing.com Nigeria
Equifax Introduces Optimal Path™ Interactive Score Planner | EFX Stock News - GuruFocus
Equifax launches AI-powered credit score planning tool for consumers - Investing.com
Equifax Unveils Game-Changing AI Credit Score Tool: Personalized Plans Show Exact Steps to Reach Target Score - Stock Titan
Analysts’ Top Industrial Goods Picks: Equifax (EFX), Chart Industries (GTLS) - The Globe and Mail
Equifax (NYSE:EFX) Given Overweight Rating at Morgan Stanley - Defense World
Kalkine : Equifax Amid Changing Sentiment and S&P 500 Chart Trends - Kalkine Media
Equifax (EFX) Price Target Raised by Morgan Stanley | EFX Stock News - GuruFocus
NL Businesses Among Canada’s Best for Debt Repayment, Equifax Reports - VOCM
Analyst Expectations For Equifax's Future - Benzinga
Equifax (EFX) Target Price Raised by Morgan Stanley Ahead of Investor Day | EFX Stock News - GuruFocus
Equifax Announces Agenda for 2025 Investor Day on June 17 | EFX Stock News - GuruFocus
Posthaste: Canadian businesses showing signs of strain not seen since 2009 - Financial Post
Equifax Announces Agenda for 2025 Investor Day on June 17 - Quantisnow
Equifax Canada Reports Rising Delinquencies and Declining Credit Demand in Q1 2025 Business Credit Trends - Nasdaq
Morgan Stanley Adjusts Price Target on Equifax to $305 From $295 - marketscreener.com
Debt Pressure Building Up for Canadian Businesses - TradingView
Your Credit Report Just Got Easier to Understand - money.com
Equifax Enhances US Consumer Credit Report Design to Help Consumers Monitor Financial Health - Crowdfund Insider
Transcript : Equifax Inc. Presents at Baird Global Consumer, Technology & Services Conference 2025, Jun-03-2025 12 - MarketScreener
Equifax (NYSE:EFX) Unveils Reimagined Credit Report Design For Easier Consumer Insights - Yahoo Finance
Equifax Redesigns U.S. Consumer Credit Report to Help Consumers More Easily Monitor Financial Health - GuruFocus
Equifax Redesigns U.S. Consumer Credit Report to Help Consumers More Easily Monitor Financial Health | EFX Stock News - GuruFocus
Equifax Revolutionizes Credit Reports: New Design Makes Credit Scores Crystal Clear - Stock Titan
Finanzdaten der Equifax Inc-Aktie (EFX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.75%
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):